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Abstract
Mycobacterium tuberculosis dosRS two-component regulatory system controls transcription of approximately 50 genes
including hspX, acg and Rv2030c, in response to hypoxia and nitric oxide conditions and within macrophages and mice. The
hspX lies between acg and Rv2030c. However, the functions of the dosR regulated genes in vitro and in vivo are largely
unknown. Previously, we demonstrated that deletion of hspX gene produced a mutant which grew faster in macrophages
and in mice. In this study, we attempted to determine the functions of acg and Rv2030c by gene inactivation. We
demonstrate that Rv2030c is dispensable for virulence and growth. However, deletion of acg produced a mutant which is
attenuated in both resting and activated macrophages and in acute and persistent murine infection models. Surprisingly,
deletion of acg did not compromise the viability of the mutant to nitrosative and oxidative stresses in vitro and in vivo. In
addition, when the WT and the acg mutants were treated with antibiotics such as the prodrugs nitrofurantoin and
nitrofuran, the acg mutant became more sensitive than the WT strain to these drugs. This suggests that Acg may not
function as a nitroreductase. These data indicate that acg encodes an essential virulence factor for M. tuberculosis and
enables it to grow and survive in macrophages and in mouse organs.
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Introduction
Tuberculosis (TB) remains one of the major infectious di-
seases, causing 8% of all deaths worldwide [1]. Currently, over two
billion people are infected with the causative agent, Mycobacterium
tuberculosis. Once infected, an individual becomes a life-long
carrier, with a 5–10% lifetime risk of contracting acute disease
[2,3]. A major biological question is the mechanisms by which M.
tuberculosis controls its virulence. Clearly, a latent state plays an
important role in which it needs to be non-virulent and non-
transmissible.
In experimental models, the latent state is thought to be
regulated by hypoxia [4] whose response in the bacterium is
controlled by the dosRS two-component regulatory system (2CR)
[5,6]. The dosRS system controls the transcription of about 50
genes under hypoxic conditions and in response to nitric oxide
[5,7]. Recent work demonstrated that the dosR regulon is regulated
by carbon monoxide which is produced by M. tuberculosis infected
macrophages and other in vitro stress conditions [8,9,10]. Also,
many genes in the dosR regulon show increased expression in
murine macrophages and in murine lung tissues [9,11,12] and
these genes may be involved in survival and persistence of the
bacterium in vivo.
Most of the genes controlled by dosR have unknown or predicted
functions. For example, narX [13], is predicted to encode a nitrate
reductase which may help the bacterium to adapt to hypoxia.
Protection against nitrogen stress is predicted [13] to be mediated
by the nitroreductase genes acg (Rv2032), Rv3127 and Rv3131. It is
thought that hspX [14,15] may be involved in latency. A recent
study using bioinformatic analysis showed that the dosR regulated
genes may be involved in carbohydrate and fatty acid metabolism
[16]. It is important to investigate if the genes within the dosRS
regulon exhibit similar or diverse functions in vivo as this will help
us to understand the biological relevance of the class of the genes
and their roles in survival and persistence of the organism in
human infection. Previously, studies using high density mutagen-
esis showed that most of the dosR regulated genes were not
essential for growth [17]. In the past, with the aim of dissecting the
potential mechanism which underlies the dosR regulatory system,
dosR has been inactivated in M. tuberculosis. Counter intuitively, this
produced a mutant that was hypervirulent in activated macro-
phages and in murine tuberculosis [18]. We made an unmarked
hspX deletion mutant of M. tuberculosis [19] which showed faster
growth in macrophages and in mice. This was also confirmed by
another study of hspX gene knock out [20]. However, later studies
produced dosR deletion mutants which either showed an
attenuated phenotype in guinea pigs, mice and rabbits [21] or
had no growth deficit in mice [22]. This raised the question as to
the in vivo functions of the genes adjacent to the hspX gene. It has
been shown previously that a hspX mutant in which hspX was
replaced by a hygromycin-resistance gene [14] was attenuated in a
macrophage model, suggesting that it is required for virulence. We
hypothesised the reason for the contradictory findings between the
hygromycin-resistance hspX gene deletion [14] and our unmarked
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deletion [19] was that the hygromycin-resistance gene deletion
mutant had alterations in the genes which are immediately
adjacent to hspX, namely acg which lies upstream, and Rv2030c
which is downstream (see Fig. 1). The hspX and acg promoters
which express divergently share the intergenic region [13,23].
Interruption of this intergenic region may affect expression of both
genes [14]. It is particularly interesting to investigate the function
of the acg gene which has been suggested to encode a putative
classical nitroreductase [13,24]. acg is one of the most upregulated
genes in the dosR regulon. The expression of acg was found to be
coregulated with that of the hspX gene under low O2 conditions,
within macrophages, especially activated macrophages and in
mice [11,13]. It has been suggested that acg might play an impor-
tant role in M. tuberculosis detoxification of nitrogen intermediates
[13]. The downstream gene Rv2030c of unknown function is co-
transcribed with hspX [15].
In this paper, we deleted acg and Rv2030c. Deletion of acg led to
an attenuated mutant in macrophage infection and in vivo acute
and persistent murine models. The M. tuberculosis mutant lacking
the Rv2030c gene was identical to the parent strain. This suggests
Figure 1. Construction of the M. tuberculosis acg and Rv2030c mutants. A. Genomic context of the genes upstream and downstream of hspX
gene. The open arrows indicate the acg or Rv2030c gene which was deleted in the mutant. The open box and the line show the location of the
fragments used for complementation of YHDacg or YHRv2030c, respectively. These were also used as probes for southern blotting analysis. B.
Southern blotting analysis to confirm the deletion of the genes. DNA from WT and YHDacg or YHRv2030c was digested with Pvu II and Btr I,
respectively and hybridised with the probes which used to make the complemented constructs. bp, molecular weight marker (Invitrogen). The
experiments were repeated twice, with identical results. C. Detection of acg mRNA in WT and YHDacg by RT-PCR. RNA was extracted from 7 day-old
cultures. M. molecular weight marker (Invitrogen). 1. RNA extracted from the WT strain, 2. DNase I-treated RNA isolated from the WT culture but no RT
enzyme. 3. PCR negative control with each primer and water instead of template. 4. RNA extracted from YHDacg. 5. DNase I-treated RNA isolated
from the acg mutant culture but no RT enzyme. 6. PCR negative control with each primer and water instead of template. 7. PCR positive control with
each primer and M. tuberculosis WT DNA.
doi:10.1371/journal.pone.0020958.g001
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PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20958
that the hspX and its adjacent genes although regulated by DosR
are functionally distinct.
Results
Construction of acg and Rv2030cmutants ofM. tuberculosis
Previously, we showed that deletion of hspX results in rapid
growth of the organism in vivo. As seen in Fig. 1A, hspX is the first
gene of a possible operon with several downstream genes RV2030c,
pfkB and Rv2028c. The intergenic region between each gene only
contains a few base pairs of nucleotides. Upstream of hspX is acg
which translates in the opposite direction. In order to verify the
essentiality of the genes adjacent to hspX in vivo, we made two M.
tuberculosis mutants which deleted acg or Rv2030c using a two-step
mutagenesis strategy [25]. The generation of the mutant strain was
confirmed by PCR (data not shown) and Southern blotting
analysis (Fig. 1B). The expression of acg gene (Fig. 1C) and Rv2030c
(data not shown) was also confirmed by RT-PCR. The M.
tuberculosis strains lacking these genes were defined as YHDacg and
YHDRv2030c, respectively. Both sequences of the PCR products
amplified from WT and the mutants were analysed by DNA
sequencing to confirm the deletion of these two genes.
The deletion of acg or Rv2030c was complemented by the intro-
duction of the integrating plasmid pUC-Gm-Int containing the
native gene and promoter into the mutant. This suicide plasmid
contains a gene which encodes the integrase of phage L5, the attP
site and a gentamicin resistant marker cassette. The gene integration
into the chromosome of the mutant was selected for gentamicin
resistance. The complemented strains were called YHacgComp and
YHRv2030cComp.
Growth and survival of YHDacg and YHDRv2030c in
macrophages
We examined the ability of both YHDacg and YHDRv2030c to
infect and proliferate within bone marrow derived macrophages
from BALB/c mice. As shown in Fig. 2A and 2B, the growth of
WT and YHDRv2030c in both resting and activated macrophages
was similar over the 7 days of infection. These data indicate that
the loss of Rv2030c has no detectable effect on intracellular survival
and proliferation. Although YHDacg was able to invade macro-
phages as seen in Fig. 2C and 2D showing similar CFU counts to
the WT strain recovered from the macrophages at time 0, the
mutant was unable to grow and survive in both resting and ac-
tivated macrophages. After three days of infection, the entire
macrophage lysates (1 ml/well) were plated on 7H11 agar. No CFU
counts of YHDacg were recovered. Similar profiles of YHDacg were
seen in the macrophage-like cell line J774A.1 (data not shown).
These results indicated that acg is essential for intracellular survival.
As the acg gene has been predicted to encode a nitroreductase
in M. tuberculosis [13], deletion of the gene might render the
bacilli sensitive to macrophage nitrogen intermediates. In order to
Figure 2. Growth and survival of M. tuberculosis YHDacg and YHDRv2030c in macrophages. Infection of YHDRv2030c in resting bone
marrow derived macrophages (A) and in IFNc activated bone marrow derived macrophages (B). Infection of YHDacg in resting bone marrow derived
macrophages (C) and in IFNc activated bone marrow derived macrophages (D). These results are the means and standard deviation derived from one
representative of three independent experiments.
doi:10.1371/journal.pone.0020958.g002
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confirm this, we infected macrophages derived from iNOS knock
out mice with M. tuberculosis WT, YHDacg and the complemented
strains. These macrophages produce reduced levels of nitric oxide
[26]. If acg was a nitroreductase, the growth of the mutant would
be restored to its parental level or to a certain extent to the
parental level. However, the YHDacg mutant failed to grow in
macrophages derived from the iNOS KO mice (Fig. S1) showing
the similar survival patterns in the macrophages derived from WT
mice (Fig. 2C and 2D).
Growth and survival of YHDacg and YHDRv2030c in mice
In order to verify if the mutants changed their virulence in acute
infection in the absence of host acquired immunity, virulence
assays of the M. tuberculosis strains in immunocompromised SCID
mice were carried out as described previously [27]. The mice were
infected intravenously with 106 CFU counts of each bacterial
strain, and the survival of the SCID mice was observed over 60
days. As shown in Fig. 3A, the mice infected with WT and
YHDRv2030c survived for 23 and 22.5 days, respectively. In
contrast, all mice infected with YHDacg, like the uninfected control
mice, survived for 60 days at which point the experiments were
terminated (Fig. 3B). The attenuation of YHDacg strain was
reversed in the acg complemented strain (Fig. 3B).
In order to examine the growth and survival of the mutants
in the face of host acquired immunity, BALB/c mice were
intravenously infected with 1.26104 CFU counts of the WT and
the mutant strains. As shown in Figure 4, typical growth of the WT
M. tuberculosis H37Rv in the immunocompetent mice was seen.
There was exponential growth for approximately three weeks, the
CFU counts of the WT reached 106 CFU/lung, followed by a
plateau as the acquired immune response inhibited the bacterial
growth. The growth of YHDRv2030c was similar to that of WT
strain (Fig. 4A and 4B). However, after infection with YHDacg
mutant, no growth of the mutant was seen, the CFU counts of the
mutant gradually decreased in both lungs and spleens (Fig. 4C and
4D) throughout the course of infection. Almost no acg mutant cells
were recovered from the infected lungs at 15 weeks of infection
which was confirmed by plating the entire lung homogenate on
7H11 agar. Growth characteristics which were similar to WT were
seen in the acg complemented strain. These data indicate that
YHDacg is attenuated.
The acg mutant stimulated less inflammatory response
To examine if the mice infected with YHDacg mutant produced
stronger inflammatory response than those infected with the WT
strain, which might inhibit the growth of the mutant in the mouse
organs, we examined the production of the proinflammatory
cytokines TNF-a, IL-6, and IL-1b in the lungs of mice infected
with the WT and YHDacg strains for 2, 3 and 6 weeks by ELISA.
As shown in Fig. 5, the mutant stimulated less cytokine production
in the host lungs, especially at 2 and 3 weeks of infection for both
TNF-a and IL6 and at 3 and 6 weeks for IL-1b.
The histopathological changes of mice infected with WT and
mutant strains were also examined. As shown in Fig. 6, the WT
infected mice developed alveolar consolidation at 3 weeks and this
was accompanied by the presence of granulomatous inflammation
containing lymphoplasmacytic cells, alveolar macrophages, neu-
trophils, and multinucleated cells at 15 weeks. In contrast, the acg
mutant infected lungs showed normal lung structure with the
alveolar space preserved throughout the lung, indicating that the
reduced host immune response and the lack of histopathological
changes were due to insufficient bacilli present in the host organs.
Response to in vitro stress
The WT, YHDacg and YHDRv2030c were grown in 7H9 broth
without disturbance for 60 days as described previously [28].
Under these conditions, the bacilli grow in the top layer of the
unagitated culture, where oxygen is available. Then they settle to
the bottom of the container, where there is a low concentration of
oxygen, and slowly adapt to microaerophilic and eventually to
anaerobic conditions. Growth characteristics of the mutants were
similar to those of the wild-type strain (data not shown), indicating
that acg and Rv2030c genes are not required for the bacterium to
grow under in vitro hypoxic conditions.
In order to investigate if stress conditions, especially those which
M. tuberculosis encounters in macrophages, affect the mutants, WT,
YHDacg, YHDRv2030c and complemented strains were exposed
to hydrogen peroxide (H2O2), nitric oxide (NO) and acidic con-
ditions. Survival of the strains was examined by CFU counting. No
increased susceptibility to NO, H2O2 and acidic conditions was
observed in these mutants in comparison to the WT strain (Fig. S2).
In order to investigate if the acg gene encoded a nitroreductase,
the WT, YHDacg and the complemented strains were incubated
with the antibiotics such as prodrugs nitrofurantoin and nitro-
furan, each containing a nitro group in its furan ring. The bacteri-
cidal activation of these drugs needs the NAD(P)H dependent
nitroreductase. The bactericidal activities of these drugs were
examined by CFU counting after two days of incubation with 7
days old cultures. As shown in Fig. 7A, the WT strain was rela-
tively tolerant to nitrofurantoin. At 200 mg/ml, about 1.6 log kill
was seen. However, YHDacg became more sensitive to it than the
Figure 3. Virulence of M. tuberculosis strains in SCID mice. A. WT,
YHDRv2030c and complemented strain. B. WT, YHDacg, and comple-
mented strain. Mice (n = 6) were infected intravenously with 106 CFU
counts of M. tuberculosis H37Rv strains. Survival of SCID mice was
observed for 60 days. The results were repeated once with reproducible
results. There were significant differences between WT and YHDacg
infected mice (P,0.0001).
doi:10.1371/journal.pone.0020958.g003
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WT strain; there was about 3 log kill at 200 mg/ml. The mutant
was exceptionally sensitive to nitrofuran causing a 6 log kill at
200 mg/ml and a 4 log kill at 100 mg/m (Fig. 7B). The CFU
counts of the WT strain were reduced to 2.5 logs and 1.6 logs at
200 and 100 mg/ml, respectively (Fig. 7B). This suggested that Acg
protein might not have nitroreductase activity to reduce the nitro
group of the drugs; otherwise deletion of the gene should render
the bacteria more resistant to the drugs.
Nitroreductase activity of YHDacg
In order to investigate if the acg mutant contained a nitro-
reductase activity, the nitroreductase activities of the WT and
YHDacg lysates were measured using GSNO or nitrofuranoin or
nitrofuran as a substrate. The Acg protein might be contained in
the cell lysate as expression of recombinant M. tuberculosis Acg in
E. coli produced a soluble protein (communication with Nicolas
Keep). As seen in Fig. 8A, addition of WT and YHDacg lysates
significantly reduced the level of GSNO. However, there is no
significant difference between WT and YHDacg in term of nitro-
reductase activity (p.0.5). The reduction of GSNO was confirmed
by using E. coli cell lysate. No nitroreductase activities were
observed using denatured cell lysates from the WT, YHDacg and
E. coli. As seen in Fig. 8B, there was a reduction of the drug
followed by addition of WT, YHDacg and E. coli proteins. Again,
there was no difference between the WT strain and the mutant in
reduction of nitrofuran. The same results were observed using
nitrofurantoin as a substrate (data not shown).
Discussion
M. tuberculosis virulence is measured by the ability of the
bacterium to invade, grow and persist in macrophages. This
infection causes host tissue damage which is characterised by the
formation of a compact cluster of cells, called a granuloma, around
the foci of infection. Here we demonstrate that the deletion of acg
yields an attenuated mutant which fails to grow and persist in
macrophages and in immune deficient and immune competent
mice. It also showed a deficit in causing tuberculosis granuloma-
tous disease. These data demonstrate that acg is an essential factor
for M. tuberculosis to establish growth in the host cells. Deletion of
Rv2030c was dispensable toM. tuberculosis virulence and persistence
in macrophages and in mice.
The hspX, acg and Rv2030c belong to the DosR regulated gene
family. Although it has been suggested that DosR is a dormancy
survival regulator [6,23,29], this supposition is only based upon
gene expression under a variety of different stress conditions, in
macrophages and in mice. Only a few reports [19] have
demonstrated discrete gene functions, for example hspX, within
the dosR regulon using allelic exchange mutants in animal infection
models. The differential expression patterns of hspX under stress
Figure 4. Growth and survival of YHDacg and YHDRv2030c in the lungs and spleen of BALBc mice. Mice were infected with 104 CFU
counts of each strain. At different time points the infected mice were sacrificed and the numbers of bacteria in the lungs and spleens were measured.
CFU counts in lungs (A) and spleens (B) in mice infected with WT, YHDRv2030c and complemented strain. CFU counts in lungs (C) and spleens (D) in
mice infected with WT, YHDacg and complemented strain. The reported values represent the average and the standard deviation obtained for each
point from three mice. The experiments have been repeated twice with similar CFU counts in lungs and spleens.
doi:10.1371/journal.pone.0020958.g004
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conditions and in vivo may be required to slow the growth of M.
tuberculosis in order to retain a non-replicating state in latency. This
is consistent with the putative function of the dosRS regulon.
However, the phenotype of the acg mutant found in this study
suggests that acg does not seem to fit into the dormancy associated
role of the dosR regulon. It is associated with full virulence of M.
tuberculosis and is required by the bacilli to sustain infection, but not
to initiate the infection process because it was able to invade
macrophages but unable to grow. Rv2030c is directly regulated by
dosR and is co-transcribed with hspX. Surprisingly, deletion of
Rv2030c has no effect on M. tuberculosis growth and persistence in
macrophages and in acute and persistent animal models. Recent
work suggested that M. tuberculosis persistence modulated by dosR
was regulated by a complex multilayer regulatory network [29].
This was strongly evidenced by the fact that deletion of hspX and
acg resulted in contradicting effects. There is significant discrep-
ancy between dosR regulated persistence and the bacterial viru-
lence in mice [22]. This was shown by the generation of a dosR
mutant which survived normally in mice although the dosR regulon
was highly upregulated in vivo [22]. Additional evidence which
supports this hypothesis comes from the data that suggests dosR
only controls the initial hypoxic response, whilst enduring hypoxic
responses are independent of dosR regulation [22]. These results,
together with our finding suggest that dosR may regulate func-
tionally diverse genes; some are involved in M. tuberculosis per-
sistence and others in M. tuberculosis virulence or in unknown
physiological and pathological roles. In addition, these findings
illustrate that information obtained by genome-wide analysis only
gives clues as to the function of genes. Discrepancies between gene
function and gene expression patterns can only be resolved by
other techniques such as gene inactivation.
How does acg contribute in M. tuberculosis growth and survival in
vivo? As described previously [13,24], sequence homology analysis
suggests that acg belongs to a nitroreductase family which consists
of oxygen-insensitive flavin-dependent enzymes that reduce nitro-
substituted compounds such as nitroaromatics quinones, and ribo-
flavin derivatives to either a hydroxylamino- or aminoaromatic
endproduct in a FMN-, FAD-dependent or NAD(P)H dependent
manner [30]. As acg is upregulated in response to NO, in
macrophages [13] and in mice [11], it has been predicted that the
product of acg may be responsible for M. tuberculosis detoxification
of nitroaromatic compounds which may be present within macro-
phages or granulomas [13]. Our results indicated that the acg
mutant was not able to grow and survive in macrophages which
produce reactive oxygen and nitrogen intermediates, acidic con-
ditions and lytic enzymes. However, unlike other M. tuberculosis
mutants which lack the oxidative and nitrosative detoxification
genes such as ahpC [31] or tpX [26], deletion of acg did not com-
promise the bacterium to grow and survive in acidic, nitric oxide
and hydrogen peroxide environments in vitro. Furthermore, the
growth and survival of the mutant was not restored in macro-
phages isolated from iNOS knockout mice. This was confirmed by
the fact that acg mutant contained the same level of nitroreductase
activity to reduce GSNO as the wild type (Fig. 8). It is not known if
the acg gene product possesses a nitroreductase activity as we are
not able to detect it using in vitro methods or using iNOS deficient
mice. Further work is underway in our laboratory to study the
enzymatic activity of the recombinant Acg protein to metabolise
nitroaromatic compounds. Surprisingly, YHDacg was more sensi-
tive than the WT strains to nitrofurantoin and especially nitro-
furan. Nitrofurans are prodrugs which exhibit antimicrobial activity
against Escherichia coli and Staphylococcus saprophyticus as well as other
facultative anaerobes, anaerobic bacterial and protozoan species
[32,33]. The antimicrobial activities of these prodrugs are largely
dependent on the rapid reduction of the 5-nitro groups by a wide
range of enzymes including the NAD(P)H nitroreductases produced
by these bacteria, which leads to accumulation of redox active
intermediates, including hydroxylamine adducts which cause
lethality to the bacterial cells. Nitrofurantoin has a relatively high
MIC against M. bovis BCG (12 mg/ml) [34] and M. tuberculosis
H37Rv (49.5 mg/ml) [35]. M. tuberculosis is relatively tolerant to
Figure 5. TNF-a, IL-6 and IL-1b levels in BALB/c mice infected
with WT and YHDacg measured by ELISA. The data shown are the
averages for the lungs from three mice 6 standard errors. Statistical
significance was determined by Student’s t test (n=3) (***, P,0.001).
doi:10.1371/journal.pone.0020958.g005
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nitrofurantoin and nitrofuran showing 1.6 and 2.5 log killing at
200 mg/ml, respectively (Fig. 7). We showed that both the WT and
YHDacg exhibited low activities to reduce nitrofuran drugs (Fig. 8).
However, YHDacg became more sensitive to the drugs. This in-
dicated that the nitrofuran drugs might function in unknown
mechanisms in M. tuberculosis which differed from the activation of
the drugs by reduction of the nitro-group. Further investigation is
underway in our laboratory.
In summary, this work demonstrates that one of theM. tuberculosis
dosR regulated genes, acg, is associated with M. tuberculosis virulence.
The acg mutant is unable to grow and survive in macrophages
and mice. This attenuation is not associated with a deficiency in
response to oxidative and nitrosative stresses. Our data suggest that
DosR may control an array of genes which shows functional diver-
sity in vitro, in macrophages and in mouse infections. We have
identified a key target against which new anti-TB drugs could be
designed, or with which a live vaccine could be developed to prevent
M. tuberculosis infection.
Materials and Methods
Ethics Statement
All animal experiments were conducted according to the Animals
Scientific Procedures Act, 1986 (an Act of the Parliament of the
United Kingdom 1986 c. 14) (Home Office Project licence Number
70/5933) with approval from St George’s, University of London
ethics committee. The animal husbandry guidelines and animal
procedure for this study were followed according to the Animals
Scientific Procedures Act, 1986. The sacrifice of the mice was per-
formed in accordance with humane end point protocols under the
Animals Scientific Procedures Act, 1986.
Bacterial strains and growth conditions
M. tuberculosis strain H37Rv was used as a parental strain to
construct the mutants. M. tuberculosis strains were grown in 7H9
medium supplemented with 10% albumin dextrose complex (ADC,
Becton Dickinson) and 0.05% Tween 80, or on 7H11 agar medium
supplemented with oleic albumin dextrose complex (OADC,
Becton Dickinson). E. coli XL2 was used as a host strain for cloning
and plasmid propagation in or on liquid and solid Luria-Bertani
medium. Antibiotics were used as follows: ampicillin (Sigma) 100
mg/ml, kanamycin (Sigma) 20 mg/ml, gentamicin (Sigma) 20 mg/ml
and hygromycin (Invitrgen) 100 mg/ml.
Mutant construction
The mutant construction was carried out in a 2-step strategy
using the pNIL/pGOAL plasmids as described previously [25].
DNA manipulations including DNA isolation, ethanol precipita-
tion of DNA, electrophoresis of DNA in agarose and transfor-
mation were performed by standard procedures [36]. Enzyme
reactions were performed according to the manufacturer’s
instructions (Invitrogene and New England Biolabs). To construct
M. tuberculosis acg deletion, a 2949 bp PCR product containing the
acg gene (996 bp) and about 1 kb flanking sequences adjacent to
each end of the gene was amplified using M. tuberculosis H37Rv
genomic DNA as template and primers acg1 (59- AATAAGCT-
TAGCAGTTCCCGACCCTCAC-39) and acg2 (59- AATAA-
GCTTCGCTATGGAACCGACGTGC -39). The PCR product
was purified from agarose gel using a QIAquick Gel Extraction
Kit (Qiagen) and was cloned into the Hind III site of pGEM3Z
(Promega) to form pGEMacg. A Nco I fragment of 777 bp in the
acg coding region was deleted. The disrupted acg gene with the
flanking sequences was cloned into the Hind III site of p2NIL [25]
to make p2NILacg1. A hyg-sacB marker cassette from the pGOAL
19 [25] was cloned into the Pac I site of p2NILacg1 to form the
final mutant construct p2NILacg2. To construct M. tuberculosis
Rv2030c deletion, a 4129 bp PCR product containing the
Rv2030c gene and 1 kb flanking sequences adjacent to each end
of the gene was amplified using M. tuberculosis genomic DNA as
template and primers Rv2030c1 (59- AATAAGCTTCGACTC-
CACCAAGTCCCAA -39) and Rv2030c2 (59- AATAAGCT-
TGGCTTCCGGGTTAACGATC -39). The PCR product was
cloned into the Hind III site of pGEM3Z (Promega) to form
pGEMRv2030c. The Rv2030c gene was deleted by PCR with
Figure 6. Hematoxylin- and eosin-stained sections of lungs in mice infected with WT and YHDacg for 3 and 15 weeks.
Histopathological examination was carried out using three mice in each group. Two sections from each mouse were examined. The data shown are
representative of lung sections from three animals in each experimental group.
doi:10.1371/journal.pone.0020958.g006
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primers Rv2030c3 59- ATTACGCGTAAACCTACCCGACC-
GGTCT-39and Rv2030c4 (59- ATTACGCGTACGGACCC-
AGTGGTCAG>TT-39) which were designed outwardly starting
from the start and stop codons of the Rv2030c gene using
pGEMRv2030c as a template. The PCR product which contains
only the flanking sequences of Rv2030c gene was cut with Mlu I
and ligated to form pGEMRv2030cD. The Rv2030c flanking
sequences containing no Rv2030c gene was cloned into the Hind
III site of p2NIL [25] to form p2NILRv2030cD1. Finally, a hyg-
sacB marker cassette from the pGOAL 19 [25] was cloned into
the Pac I site of p2NILRv2030cD to form the final mutant con-
struct p2NILRv2030cD2. Plasmid DNA was isolated with a
QIAprep Spin Miniprep Kit (Qiagen). The sequences of purified
PCR products were determined commercially (QIAGEN). Both
DNA strands were sequenced by using the two primers that were
used to generate each PCR product. The plasmids p2NILacg2
and p2NILRv2030cD2 were electroporated into M. tuberculosis
H37Rv cells, respectively, and the selection of the mutants was
performed as described previously [25,37].
To complement the acg deletion, a 1395 bp DNA fragment
containing the acg gene and 324 bp of upstream sequence was
amplified by PCR using primers acgC1 59- AATAAGCTTTC-
CAGCCGCATCAACCGGGT-39) and acgC2 (59- AATAA-
GCTTTCGCCGGATCCGCTCATCGA -39). The PCR prod-
uct was cloned into the Hind III sites of the integrating plasmid
pUC-Gm-Int [38]. For complementation of Rv2030c mutant, a
2796 bp PCR product amplified using primer Rv2030c5 (59- AT-
TTCTAGAGTCACCATGGTGTCCGGCAT-39) and Rv2030c6
(59-ATTTCTAGATCCAAGGCGGGGTTCATGGT-39) contain-
ing 216 bp of the upstream sequence of hspX gene, hspX gene and
Rv2030c was cloned into the Hind III sites of pUC-GM-Int. The
constructs of complementation were electroporated into YHDacg and
YHDRv2030c mutants, respectively, and GmR transformants were
selected.
Estimation of viability under in vitro stress conditions
M. tuberculosis strains were grown in 7H9 medium containing
0.05% Tween 80 supplemented with 10% ADC for 10–15 days. A
series of 10 ml standing cultures were used for the determination
of CFU counts after exposure to stress. For oxidative stress,
hydrogen peroxide (H2O2) (5 mM and 10 mM) was added to the
cultures. For nitric oxide (NO) stress, diethylenetriamine/nitric
oxide adduct (DETA/NO) and S-Nitrosoglutathione (GSNO)
were added to the cultures at the final concentrations of 5 and
10 mM, and the cultures were incubated at 37uC. For treatment
with drugs containing a nitro group, nitrofurantoin and 2-
nitrofuran were incubated with cultures at the final concentrations
of 200, 100, 50, 25, 12.5, 6.25, 3.125 and 0 mg/ml. For acidic
stress, the culture medium was replaced with acidic 7H9 medium
(pH 4). CFU counts of the treated cultures and the non-treated
cultures were determined at 0 and 7 days (acidic conditions), at 0
and 24 hours (H2O2, DETA/NO and GSNO) or 0 and 48 hours
(nitrofurantoin and nitrofuran). Each stress treatment was carried
out in triplicate.
Nitroreductase assay
Nitroreductase activity was measured using cell lysates of WT,
YHDacg and E. coli K12 with GSNO, 2-nitrofuran or nitrofuran-
toin as a substrate. M. tuberculosis strains were grown in 7H9
medium containing 0.05% Tween 80 supplemented with 10%
ADC without disturbance for 7 days. E. coli was grown in nutrient
broth overnight at 37uC with constant shaking at 120 rpm.
Bacterial numbers of the cultures were determined by optical
density reading at 600 nm and CFU counts. The cultures were
washed three times in chilled 50 mM Tris-HCI (pH 7.5) and were
then resuspended in the same buffer. The cell suspension was
transferred into 2 ml tubes each containing 75 to 150 mm glass
beads and lysed by homogenisation using a FastPrep Instrument
(Fisher Scientific) for 40 seconds at 6.5 speed. The cell debris was
removed by centrifugation at 13,000 rpm for 20 minutes at 4uC
followed by filtration. Total protein concentrations of the cell
lysates were determined with the Bio-Rad protein assay using
bovine serum albumin as a standard. The reduction of GSNO or
nitrofuran drugs was determined by a decrease in the absor-
bance at 335 nm for GSNO (molar extinction coefficient 586
M21cm21) [39], at 373 nm for nitrofurantoin (molar extinction
coefficient of 2.636104 M21cm21) [40] and at 340 nm for 2-
nitrofuran. The reaction mixture (1 ml) consisted of enzyme
preparation, 50 mM Tris-HCl (pH 7.0), 5 mM GSNO or
0.5 mM nitrofurantoin and 2-nitrofuran, and 0.1 mM NADPH.
Equal amounts of the WT and the mutant proteins were used in
each preparation.
Figure 7. Survival of YHDacg in response to nitrofuran drugs.
The WT, YHDacg and the complemented strains were treated with
nitrofurantoin (A) and nitrofuran (B) at different concentrations for
48 hours. These results are the means and standard deviation derived
from one representative of three independent experiments. Statis-
tical significance was determined by Student’s t test (n = 3) (***,
P,0.001).
doi:10.1371/journal.pone.0020958.g007
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Mouse infection models
BALB/c mice (6 to 8 weeks old, female, body weight 18–20 g)
were used (Harlan UK Ltd). M. tuberculosis cells were resusupended
in phosphate-buffered saline (PBS) and were intravenously injected
into the mouse with 1.26104 CFU of the bacterial cells. At
different time points, spleens and lungs from 4 mice were removed
rapidly after sacrifice and a sterile autopsy was performed. The
organs were transferred into 2 ml tubes each containing 1 ml
sterile distilled water and 2 mm diameter glass beads. Lungs and
spleens of the mice were homogenised using a reciprocal shaker
(Thermo Hybaid Ltd) for 40 seconds at 6.5 speed. CFU counts
from each lung and spleen were performed using serial dilutions of
the homogenates.
Virulence assays of the M. tuberculosis strains with SCID mice (6
to 8 weeks old, female, Harlan UK Ltd) were carried out as
described previously [27]. 9 mice in each group were intrave-
nously infected with 106 CFU of the WT, mutant and the
complemented strains. After 4 hours of infection, three mice in
each group were sacrificed and CFU counts in lungs and spleens
were estimated. The remaining 6 infected mice were observed for
Figure 8. Measurements of nitroreductase activities in YHDacg using GSNO (A) or nitrofuran (B) as a substrate. Presence of
nitroreductase activities was measured by the reduction of the substrate using the bacterial cell lysates at 24 hours for GSNO and 48 hours for
nitrofuran. The cell lysate extracted from E. coli was added as a positive control. The denatured cell lystaes which were produced by boiling the cell
lysates at 100uC for 10 minutes were included as the negative control. The experiments were repeated twice with the similar results.
doi:10.1371/journal.pone.0020958.g008
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60 days and the death time for each group was recorded. Median
survival times were calculated for each group, and statistical
analysis was performed using the log rank tests of survival.
Macrophage infection
Bone marrow-derived macrophages were isolated from BALB/
c, C57BL/6 and the iNOS KO (Inducible Nitric Oxide Synthase
Knockout) mice and cultured for 7 days as described previously
[27]. Also macrophage J774A.1 cell line was used. Adherent
macrophages were harvested and seeded at 26105 cells per well of
24 well plates in Dulbecco’s Modified Eagle Medium (Invitrogen)
without L-cell conditioned medium, penicillin and streptomycin.
Activation of macrophage cells was carried out by the addition of
interferon-c (IFN-c, 100 U/ml. R&D Systems) for 24 h, followed
by the addition of lipopolysaccharides (LPS, 200 ng/ml, Sigma)
for 3 h. The cells were infected with the bacterial strains at a
multiplicity of infection of 1:1 for 4 hours, then washed 6 times
with warm Hank’s Buffered Salt Solution (HBSS). At 0, 3, 5 and 7
days after infection, the cells were washed and lysed with 0.1%
Triton-X 100, and CFU counts were performed. At each time
point, the infected macrophages in two wells were individually
harvested using Trypsin-EDTA and stained for acid-fast bacilli
(AFB) in order to check macrophage viability. The experiments
were carried out three times in triplicate.
Supporting Information
Figure S1 Growth and survival of YHDacg in resting and
IFN-c-activated macrophages derived from iNOS knock-
out mice. These results are the means and standard deviation
derived from one representative of three independent experiments.
(EPS)
Figure S2 Survival of YHDacg and YHDRv2030c in
response to DETA/NO at 5 and 10 mM (A), H2O2 at 5
and 10 mM (B), and under acidic condition (C). The data
shown is a representative of three independent experiments. Data
are represented as mean 6 SD of triplicate tests.
(EPS)
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